Cytomegalic Inclusion Disease - 21 Studies Found Recruiting : Certican® (Everolimus) Against Cytomegalovirus Disease in Renal Transplant Patients : Cytomegalovirus Disease : 2009-01-23 : Drug: Certican (everolimus) + valganciclovir Completed : Cytogam Administration in Abdominal Organ Transplant Recipients at High Risk for Cytomegalovirus Infection : Cytomegalovirus Disease : 2012-01-10 : Drug: Valganciclovir Valcyte p Completed : A Study of MCMV5322A/MCMV3068A for the Prevention of Cytomegalovirus Disease in High-Risk Kidney Allograft Recipients : Cytomegalovirus Infections : 2012-12-17 : Drug: MCMV3068A Four doses of Terminated : SUSTAIN: A Randomized, Double-Blind, Multicenter, Phase 3 Study of the Efficacy, Safety, and Tolerability of Brincidofovir Versus Valganciclovir for the Prevention of Cytomegalovirus Disease in CMV Seronegative Kidney Allograft Recipients : Cytomegalovirus Disease : 2015-05-07 : Drug: Brincidofovir Other Name Completed : Quantiferon - Cytomegalovirus (CMV) and the Prediction of CMV Infection In High Risk Solid Organ Transplant Recipients : Cytomegalovirus Infection : 2008-10-15 Recruiting : Evaluation of the PK and PD of Ganciclovir in Premature Infants Receiving Treatment for CMV Infection : Cytomegalovirus Infections : 2012-05-17 Completed : Efficacy Study of Human Cytomegalovirus (HCMV) Hyperimmune Globulin to Prevent Congenital HCMV Infection : Cytomegalovirus Infection : 2009-04-14 : Drug: HCMV-specific hyperimmune globulin (Cytotect®) Active, not recruiting : A French Cohort of Transplant Recipients With CMV Infection : Risk Factors for Antiviral Resistance in the Prophylaxis Era. : Transplant Recipients With CMV Infection : 2014-02-14 : Biological: CMV Infection Routine follow-up (viral load, creatininaemia, neutrophil count, isolation of Completed : gB/MF59 Vaccine in Preventing Cytomegalovirus Infection in Healthy Adolescent Females : Cytomegalovirus Infections : 2005-08-19 : Biological: MF-59 Microfluorid Completed : Maribavir for Treatment of Resistant or Refractory CMV Infections in Transplant Recipients : Cytomegalovirus Infections : 2012-06-01 : Drug: Maribavir Tablet for oral administration Next >>>
